Sign in
4

Changes in Ownership

NRX Pharmaceuticals, Inc. Filed Acc 0000950142-22-003233

Director bought 500,000 shares at an average $1.03 ($514,905)

From the SEC's structured data for this filing

Trades in this filing

Hurvitz Chaim · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-11-16 Purchase : show line 1 in the form +287,812 $0.99 $284,934 287,812 D
2022-11-17 Purchase : show line 2 in the form +171,780 $1.08 $185,522 459,592 D
2022-11-18 Purchase : show line 3 in the form +40,408 $1.10 $44,449 500,000 D
Open-market purchases · 500,000 sh · avg $1.03 · $514,905

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-10-21 Grant or award : show line 4 in the form Employee Stock Option +162,660 381,083 D
Loading xslF345X03/es220307158_4-hurvitz.xml…